Phosphoinositide 3-kinase in Health and Disease Volume 1 /

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Outros autores: Rommel, Christian. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vanhaesebroeck, Bart. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vogt, Peter K. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Formato: Electrónico eBook
Idioma:English
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Series:Current Topics in Microbiology and Immunology, 346
Subjects:
Acceso en liña:https://doi.org/10.1007/978-3-642-13663-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!